Immediate Impact
1 from Science/Nature 64 standout
Citing Papers
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
2025 Standout
Works of Mayu Higuchi being referenced
Hepatitis B core‐related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen‐negative chronic hepatitis B patients
2021
Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarate
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mayu Higuchi | 396 | 415 | 53 | 60 | 37 | 558 | |
| Kenta Takaura | 377 | 403 | 54 | 63 | 41 | 536 | |
| Hsing‐Tao Kuo | 466 | 426 | 39 | 26 | 50 | 609 | |
| Jean‐Charles Renversez | 241 | 256 | 81 | 49 | 35 | 578 | |
| Jiro Ikoma | 404 | 339 | 66 | 34 | 32 | 644 | |
| Chisa Kondo | 277 | 325 | 37 | 57 | 45 | 468 | |
| B.E. Annicchiarico | 364 | 305 | 38 | 47 | 28 | 507 | |
| Norio Itokawa | 277 | 324 | 51 | 59 | 53 | 496 | |
| Delphine Weil | 351 | 336 | 45 | 26 | 33 | 524 | |
| Maciej Jabłkowski | 222 | 278 | 43 | 58 | 43 | 494 | |
| Fujimasa Tada | 249 | 370 | 24 | 43 | 34 | 543 |
All Works
Loading papers...